Singapour #3793 (v.3)
Données de base
- Notifiée dans
- Validité de la version
-
01/10/2020 -
actuelle
Version active v.3
- Membre présentant le rapport
- Singapour
- En vigueur depuis
- Date de fin
- En vigueur
- Description générale
-
Non-automatic licence for the import of Cell and Tissue Therapy Products and Chinese proprietary medicines
- Base légale nationale
-
Medicines Act; 1975
- Mécanisme administratif
-
While the controls of chemical and biologic drugs have been transferred from the Medicines Act to the Health Products Act from 1 Nov 2016, cell and tissue –based products and CPMs will continue to be regulated under the Medicines Act for now.
More information can be found at: https://www.hsa.gov.sg/.
Administered by HSA. - Entités responsables
-
Health Sciences Authority
- Version du SH
-
HS 2017
- Cote du document de l'OMC mentionné
Métadonnées
- Justifications au regard de l'OMC
-
XX:(b) - (b) necessary to protect human, animal or plant life or health;
GATT 1994 (GATT 1947 provisions)
Signalé comme: Article XX(b) of the GATT - Engagements internationaux (hors OMC)
-
- Partenaires concernés
- Partenaires non concernés
Mesures
- Restrictions signalées
- NAL
| Cote |
|---|
|
NAL
|
Lignes tarifaires
|
|
NA
|
Cell and tissue therapy products refer to cellular and tissue based medicinal products. Chinese prop...
|
|